Two Sigma Advisers’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-12,200
Closed -$51K 2940
2022
Q1
$51K Sell
12,200
-22,500
-65% -$75.4K ﹤0.01% 2589
2021
Q4
$88K Buy
34,700
+8,800
+34% +$29K ﹤0.01% 2424
2021
Q3
$102K Sell
25,900
-24,900
-49% -$124K ﹤0.01% 2321
2021
Q2
$326K Buy
50,800
+13,000
+34% +$89.6K ﹤0.01% 2110
2021
Q1
$306K Sell
37,800
-7,100
-16% -$65.2K ﹤0.01% 2214
2020
Q4
$377K Sell
44,900
-7,700
-15% -$52.1K ﹤0.01% 1969
2020
Q3
$218K Buy
52,600
+36,400
+225% +$155K ﹤0.01% 2127
2020
Q2
$74K Buy
+16,200
New +$74.3K ﹤0.01% 2399

Other funds holding GMDA

Two Sigma Advisers's GMDA Position: Q2 2022 in Review

Two Sigma Advisers sold out of Gamida Cell Ltd. Ordinary Shares (GMDA) in Q2 2022, closing a stake of 12,200 shares — an estimated $51K sold.

Two Sigma Advisers first reported a position in GMDA in Q2 2020 and held it in 8 quarters. The position peaked at $377K in Q4 2020. 57 funds tracked by Wall St. Rank hold GMDA as of Q2 2022.

  • Two Sigma Advisers reported no remaining Gamida Cell Ltd. Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 12,200 Gamida Cell Ltd. Ordinary Shares shares in Q2 2022, an estimated $51K.
  • Two Sigma Advisers first reported a position in Gamida Cell Ltd. Ordinary Shares in Q2 2020 and held it in 8 quarters.
  • Two Sigma Advisers's Gamida Cell Ltd. Ordinary Shares position peaked at $377K in Q4 2020.
  • 57 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q2 2022.

Based on Two Sigma Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.